| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |